HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Primary sarcoma of the adult vagina: a clinicopathologic study.

Abstract
Combination chemotherapy has dramatically improved the results of treatment for embryonal rhabdomyosarcoma of the vagina in children, but little attention has been directed toward vaginal sarcomas in adults. This report of 17 cases of primary sarcoma of the adult vagina includes ten leiomyosarcomas, four mixed mesodermal tumors, one undifferentiated sarcoma, one stromal sarcoma, and one neurofibrosarcoma. The leiomyosarcomas, mixed mesodermal tumors, and the stromal sarcoma were morphologically similar to their uterine counterparts. Thirty-five percent of the patients had received pelvic irradiation for carcinoma of the cervix. Three of four patients treated by pelvic exenteration are alive and disease free after 84 to 161 months of observation. All 13 patients who received other forms of primary therapy died of recurrence. The pelvis was the first site of recurrence in all treatment failures and the only site of failure in 50%.
AuthorsW A Peters 3rd, N B Kumar, W A Andersen, G W Morley
JournalObstetrics and gynecology (Obstet Gynecol) Vol. 65 Issue 5 Pg. 699-704 (May 1985) ISSN: 0029-7844 [Print] United States
PMID2984620 (Publication Type: Journal Article)
Topics
  • Adenocarcinoma (pathology, radiotherapy, surgery)
  • Adult
  • Aged
  • Combined Modality Therapy
  • Female
  • Humans
  • Hysterectomy
  • Leiomyosarcoma (pathology, radiotherapy, surgery)
  • Middle Aged
  • Neoplasms, Germ Cell and Embryonal (pathology, radiotherapy, surgery)
  • Sarcoma (pathology, radiotherapy, surgery)
  • Vagina (surgery)
  • Vaginal Neoplasms (pathology, radiotherapy, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: